Abstract
The MHC class II transactivator (CIITA) is the master regulator for HLA-D (DP, DQ, DR) gene expression. In this report the coding and promoter regions of the CIITA gene, MHC2TA, were evaluated for polymorphisms in 50 normal Caucasian individuals. Allele frequencies were obtained for four separate single nucleotide (nt) polymorphisms (SNPs) identified in the MHC2TA coding region: nt 1614 (C→G), nt 2509 (G→A), nt 2536 (T→G), and nt 2791 (G→A). MHC2TA sequence analysis of 100 chromosomes from these 50 individuals revealed a SNP in MHC2TA promoter (p) III at nt −155 (A→G), but none in CIITA pI or pIV. In addition, we demonstrate the presence of splice variant at a previously undiscovered intron, accounting for a three nt (TAG) insertion at position 474 that was originally described in association with one of the disease-causing CIITA cDNA mutations in bare lymphocyte syndrome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mach B, Steimle V, Martinez-Soria E, Reith W . Regulation of MHC class II genes: lessons from a disease Ann Rev Immunol 1996 14: 301–331
Chang C-H, Flavell RA . Class II transactivator regulates the expression of multiple genes involved in antigen presentation J Exp Med 1995 181: 765–767
Wolf PR, Ploegh HL . How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway Ann Rev Immunol 1995 11: 267–306
Waldburger JM, Masternak K, Muhlethaler-Mottet A et al. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression Immunol Rev 2000 178: 148–165
Haines JL, Ter-Minassian M, Bazyk A et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group Nat Genet 1996 13: 469–471
Haines JL, Garcia ME, Barcellos L, Oksenberg JR, Hauser SL, Pericak VM . Chromosome 16p13-cen and the MHC in multiple sclerosis Am Soc Hum Gen 1999 65 (Suppl): A252 (Abstr. 1406)
Sartoris S, Brendolan A, Degola A et al. Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability Hum Immunol 2000 61: 599–604
Steimle V, Otten LA, Zufferey M, Mach B . Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome) Cell 1993 75: 135–146
Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM . Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA) Immunity 1995 2: 533–543
Stephens RM, Schneider TD . Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites J Mol Biol 1992 228: 1124–1136
Sims TN, Elliot JF, Ramassar V, Denney DW Jr, Halloran PF . Mouse class II transactivator: cDNA sequence and amino acid comparison with the human transactivator Immunogenetics 1997 45: 220–222
Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B . Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA EMBO J 1997 16: 2851–2860
Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP-Y . Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-γ-regulated expression of the class II transactivator gene J Immunol 1998 160: 233–240
Soos JM, Morrow J, Ashley TA, Szente BE, Bikoff EK, Zamvil SS . Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells J Immunol 1998 161: 5959–5966
Dong Y, Rohn WM, Benveniste EN . IFN-γ regulation of the type IV class II transactivator promoter in astrocytes J Immunol 1999 162: 4731–4739
Rasmussen HB, Kelly MA, Clausen J . Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3′ untranslated region of the major histocompatibility complex class II transactivator gene Hum Immunol 2001 62: 371–377
Acknowledgements
We thank Drs Christian von Büdingen and Sergio Baranzini for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Additional information
Support for this work was provided to SSZ by the Alexander M and June L Maisin Foundation, the Hellman Family Foundation, the National Institutes of Health (Grant no. K02 NS02207), the National Multiple Sclerosis Society (NMSS) (Grant no. RG 3206) and the Nancy Davis Center Without Walls, to JRO by the NMSS (Grant no. RG2901) and to JFP by the NMSS (Grant no. 3273). OS is supported by an NMSS postdoctoral fellowship.
Rights and permissions
About this article
Cite this article
Patarroyo, J., Stuve, O., Piskurich, J. et al. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). Genes Immun 3, 34–37 (2002). https://doi.org/10.1038/sj.gene.6363808
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363808
Keywords
This article is cited by
-
Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cells
Scientific Reports (2021)
-
The expanding genetic overlap between multiple sclerosis and type I diabetes
Genes & Immunity (2009)
-
CATERPILLERs, pyrin and hereditary immunological disorders
Nature Reviews Immunology (2006)